• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

New England Journal of Medicine: Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone

nola_mnr

Well-known member
http://www.nejm.org/doi/full/10.1056/NEJMoa1411680#t=articleTop

[...]
Here, we present the available data on the first 106 patients in whom EVD was diagnosed as the disease spread to Sierra Leone in order to provide a basis for understanding the clinical illness.
[...]
These relationships allowed us to observe incubation periods of 6 to 12 days, which is similar to that observed in the outbreak overall.
[...]
Patients who were younger than 21 years of age had a significantly lower case fatality rate than did patients older than 45 years of age (57% vs. 94%, P=0.03[...])
[...]
Patients between the ages of 21 and 45 years had an intermediate case fatality rate of 74%. There was no significant difference in the case fatality rate between males and females (73% and 75%, respectively).
[...]
A positive correlation was noted between the viral load and the risk of death. Patients who presented with fewer than 100,000 EBOV copies per milliliter of serum had a case fatality rate of 33%, whereas those with a viral load of 10 million EBOV copies per milliliter or more had a significantly higher case fatality rate of 94% (P=0.003)
[...]
Although biased by the case definition, common findings included fever (in 89% of the patients), headache (in 80%), weakness (in 66%), dizziness (in 60%), diarrhea (in 51%), abdominal pain (in 40%), sore throat (in 34%), vomiting (in 34%), and conjunctivitis (in 31%)
[...]Among patients with diarrhea, 94% died, whereas only 65% of those without diarrhea on presentation died. Evidence of bleeding was noted in only 1 patient. None of the other 43 patients were reported to have hemorrhagic signs during their hospital stays, but the possibility cannot be definitively excluded because of the limited charting.
[...]
A documented fever (temperature, >38?C [100.4?F]), weakness, dizziness, and diarrhea on presentation were also associated with a fatal outcome. A number of dysfunctional hematologic and blood-system features have been described in experimental animals infected with EBOV.
[...]
Only 1 of 106 patients in our study cohort had overt bleeding at presentation. Although bleeding has been noted in previous outbreaks, our results show that this symptom is rare in the current outbreak.
[...]
 
Re: New England Journal of Medicine: Clinical Illness and Outcomes in Patients with Ebola in Sierra Leone

Vital signs were recorded at presentation and every 6 hours thereafter. A fever (temperature, >38.4°C [101.1°F]) was recorded at the time of initial presentation in 13% of the patients, whereas a temperature of 38°C (100.4°F) or more was noted in 29%. Temperature was the only vital sign that correlated with survival (Figure 3AFigure 3Vital Signs in Patients with Fatal and Nonfatal EVD., and Table S6 in the Supplementary Appendix). The mean temperature at the time of admission was significantly higher among patients who died than among those who survived (37.5°C [99.5°F] vs. 35.9°C [96.6°F], P=0.001).

13 + 29 = 42%. This table indicates that a portion of other cases had milder fever at presentation, with maybe 10% or so having no fever at presentation. It also shows that confusion at presentation is associated only with fatal cases.
 
Back
Top